Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity.

We recently showed that Helicobacter pylori (HP)-positive gastric 'pure' diffuse large B-cell lymphoma (DLBCL) may respond to HP eradication therapy. However, whether these HP-related 'pure' DLBCL of the stomach may differ fundamentally from those unrelated to HP remains unclear. In this study, we compared the clinicopathologic features of these two groups of patients who had been uniformly treated by conventional chemotherapy. Forty-six patients were designated HP-positive and 49 were HP-negative by conventional criteria. HP-positive patients had a lower International Prognostic Index score (0-1, 65% vs 43%, P=0.029), a lower clinical stage (I-IIE1, 70% vs 39%, P=0.003), a better tumor response to chemotherapy (complete pathologic response, 76% vs 47%, P=0.004) and significantly superior 5-year event-free survival (EFS) (71.7% vs 31.8%, P<0.001) and overall survival (OS) (76.1% vs 39.8%, P<0.001). To draw a closer biologic link with HP, HP-positive tumors were further examined for CagA expression in lymphoma cells. Compared with CagA-negative cases (n=16), CagA-positive cases (n=27) were associated with high phosphorylated SHP-2 expression (P=0.016), and even better 5-year EFS (85.2% vs 46.3%, P=0.002) and OS (88.9% vs 52.9%, P=0.003). HP-related gastric 'pure' DLBCL may be a distinct tumor entity, which is less aggressive, and responds better to conventional chemotherapy.

Efficient high-power terahertz beating in a dual-wavelength synchronously mode-locked laser with dual gain media.

We originally present a novel tactic to accomplish a compact efficient dual-wavelength synchronously mode-locked laser by physically combining the Nd:YVO4 crystal to the Nd:GdVO4 crystal as a composite gain medium. With the developed method, the total output power at 1.06 µm could be effectually produced to reach 1.3 W under the optimally balanced two-color intensities. The corresponding mode-locked pulse width and repetition rate are measured to be 47 ps and 2.86 GHz, respectively. Through the optical beating between two carrier frequencies of dual-color synchronous pulses, a train of 0.32 THz ultrashort pulses is further generated with the effective duration of down to 1.6 ps.

High-power tunable single- and multi-wavelength diode-pumped Nd:YAP laser in the (4)F3/2 → (4)I11/2 transition.

We experimentally explore the fluorescent spectrum of the Nd:YAP crystal to manifest the feasibility of tunable single- and multi-wavelength operations in the (4)F3/2 → (4)I11/2 transition. An intracavity etalon is subsequently exploited to effectively select spectral lines at 1073, 1080, and 1084 nm with the tunabilities of 0.56, 1.13, and 0.1 nm, respectively. We also experimentally obtain multi-wavelength oscillations among various intermanifold lines in the Nd:YAP crystal with the output powers on the order of several watts for each group. Employing the Cr(4+):YAG crystal to realize the passively Q-switched operation, the maximum average output powers as high as 2.3 and 3.5 W for 1073 and 1080 nm are obtained. The corresponding pulse energies at 1073 and 1080 nm are up to 177 and 159 µJ, respectively.

Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significance.

We previously reported that CagA can be translocated into B cells in Helicobacter pylori (HP) coculture media, and the translocation appears biologically significant as activation of the relevant cellular pathways was noticed. In this study, we further explore if CagA can be detected in malignant B cells of HP-positive gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Expression of CagA was evaluated by immunohistochemistry. CagA expression was further confirmed by western blot analysis. The association between CagA expression in malignant B cells and tumor response to HP eradication therapy (HPE) was evaluated in 64 stage IE gastric MALT lymphoma patients. We detected CagA expression in 31 (48.4%) of 64 patients: 26 (68.4%) of the 38 HP-dependent cases and 5 (19.2%) of the 26 HP-independent cases (P<0.001). Patients with CagA expression responded to HPE quicker than those without (median time to complete remission, 3.0 vs 6.5 months, P=0.025). Our results indicated that CagA can be translocated into malignant B cells of MALT lymphoma, and the translocation is clinically and biologically significant.

Efficient high-energy passively Q-switched Nd:YLF/Cr4+:YAG UV laser at 351 nm with pulsed pumping in a nearly hemispherical cavity.

We originally utilize a nearly hemispherical cavity to accomplish the energy scale-up for a high-repetition-rate nanosecond pulsed pumped Nd:YLF laser passively Q-switched by the Cr(4+):YAG saturable absorber. This compact laser is able to efficiently generate pulse energy as large as 1.38 mJ and pulse width as short as 5 ns under a pulse repetition rate of 100 Hz. Further employing the developed Nd:YLF laser to perform extracavity harmonic generations, the maximum pulse energies of 490 µJ at 527 nm and 360 µJ at 351 nm are achieved with the shortest pulse duration of 4 ns.

Tunable GHz pulse repetition rate operation in high-power TEM(00)-mode Nd:YLF lasers at 1047 nm and 1053 nm with self mode locking.

We report on a high-power diode-pumped self-mode-locked Nd:YLF laser with the pulse repetition rate up to several GHz. A novel tactic is developed to efficiently select the output polarization state for achieving the stable TEM(00)-mode self-mode-locked operations at 1053 nm and 1047 nm, respectively. At an incident pump power of 6.93 W and a pulse repetition rate of 2.717 GHz, output powers as high as 2.15 W and 1.35 W are generated for the σ- and π-polarization, respectively. We experimentally find that decreasing the separation between the gain medium and the input mirror not only brings in the pulse shortening thanks to the enhanced effect of the spatial hole burning, but also effectively introduces the effect of the spectral filtering to lead the Nd:YLF laser to be in a second harmonic mode-locked status. Consequently, pulse durations as short as 8 ps and 8.5 ps are obtained at 1053 nm and 1047 nm with a pulse repetition rate of 5.434 GHz.

Reinvestigating hyperpolarized (129)Xe longitudinal relaxation time in the rat brain with noise considerations.

The longitudinal relaxation time of hyperpolarized (HP) (129)Xe in the brain is a critical parameter for developing HP (129)Xe brain imaging and spectroscopy and optimizing the pulse sequences, especially in the case of cerebral blood flow measurements. Various studies have produced widely varying estimates of HP (129)Xe T(1) in the rat brain. To make improved measurements of HP (129)Xe T(1) in the rat brain and investigate how low signal-to-noise ratio (SNR) contributes to these discrepancies, we developed a multi-pulse protocol during the washout of (129)Xe from the brain. Afterwards, we applied an SNR threshold theory to both the multi-pulse protocol and an existing two-pulse protocol. The two protocols yielded mean +/- SD HP (129)Xe T(1) values in the rat brain of 15.3 +/- 1.2 and 16.2 +/- 0.9 s, suggesting that the low SNR might be a key reason for the wide range of T(1) values published in the literature, a problem that might be easily alleviated by taking SNR levels into account.

Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.

We recently reported that low-grade mucosa-associated lymphoid tissue lymphoma (MALToma) and diffuse large B-cell lymphoma (DLBCL) with MALToma (DLBCL[MALT]) of stomach are equally responsive to H. pylori eradication therapy (HPET) and that H. pylori-independent status is closely associated with nuclear translocation of BCL10. However, co-existing MALToma and DLBCL components of gastric DLBCL(MALT) may respond differentially to HPET and the underlying mechanism remains unclear. Tumour tissue samples from 18 patients with microdissectable co-existing MALToma and DLBCL cells were studied. The clonality of lymphoma cells was examined by polymerase chain reaction-based amplification of the CDR3 region of the IgH gene and confirmed by DNA sequence analysis. BCL10 expression was determined by immunohistochemistry. Differential response of co-existing MALToma and DLBCL to HPET was defined as complete eradication of one component while the other component remained. Five (27.8%) of the 18 patients showed different IgH gene rearrangements in the two components and three (60%) of these five patients had differential response of MALToma and DLBCL to HPET. By contrast, 13 patients showed identical IgH gene rearrangements and only one (8%) of them had differential response of the two components to HPET (p = 0.044). Further, all four patients with differential response of MALToma and DLBCL to HPET showed nuclear expression of BCL10 in the H. pylori-independent component and cytoplasmic expression of BCL10 in the H. pylori-dependent component while the expression patterns of BCL10 were identical in both of these components in the 14 patients who had similar tumour response to HPET. We conclude that different clonality is a common reason for the differential response of co-existing MALToma and DLBCL of gastric DLBCL(MALT) to HPET and that immunohistochemical examination of BCL10 expression may help to identify the co-existence of these components.

Alterations of p16/MTS1 gene in oral squamous cell carcinomas from Taiwanese.

To determine the alterations of the p16/MTS1 gene in oral squamous cell carcinoma (OSCC), we examined in Taiwanese patients the mutation, deletion and methylation of p16/MTS1 in primary OSCCs associated mostly with betel quid (BQ)/tobacco use. Among 110 tumors undergoing mutational analyses, seven (6%) showed mutations in exon 2 or the intron 1/exon 2 splice site. All but one mutation disrupted the encoded proteins. Base transitions represented the vast majority (6/7) of the mutations identified in BQ/tobacco consuming subjects. It was noted that 15/56 (27%) tumors examined by restriction fragment methylation analysis revealed a significant level of methylation in different loci of exon 1 as compared with the respective non-cancerous tissue. Mutation of p16/MTS1 was exclusively identified in carcinomas of buccal mucosa, whereas methylation of the p16/MTS1 promoter region occurred preferentially in carcinomas of the tongue (54%) rather than at other sites (22%). Homozygous deletion was not found in 56 paired samples examined, nor was hemizygous deletion indicated in 12 informative cases. The results indicated aberrant methylation and mutation as the molecular abnormality of p16/MTS1 in the OSCC from Taiwanese.

Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.

Cryptic t(12;21)(p12-13;q22) leading to TEL-AML1 fusion has recently been recognized as the most frequent genetic rearrangement in childhood acute lymphoblastic leukemia (ALL) in Western countries. More recently, we found a similar frequency of this abnormality in Chinese children with ALL in Taiwan. In this study, we assessed further the frequency of TEL-AML1 fusion as well as that of BCR-ABL in Chinese adults with ALL, using reverse transcriptase-polymerase chain reaction assays. Among the 81 cases with newly diagnosed B lineage ALL studied, none had the TEL-AML1 fusion whereas 30 had the BCR-ABL fusion. The lack of cases with the TEL-AML1 fusion together with the high frequency of BCR-ABL fusion could largely account for the poorer outcome of adult ALL as compared with childhood ALL.